Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This program has received an unrestricted educational grant or in-kind support from Roche.